TMI-1 is a novel orally bioavailable inhibitor of ADAM17 (TACE) and MMP, inducing tumor apoptosis in a breast cancer. References: Vigouroux F, Rabarin F, Jeudy J, Bigorre N, Saint Cast Y, Pechmajou L, Raimbeau G. Peritrapezial osteoarthritis: Inter- and intraobserver reliability of the Allieu classification. Hand Surg Rehabil. 2017 Oct;36(5):363-367. doi: 10.1016/j.hansur.2017.06.008. Epub 2017 Aug 16. PubMed PMID: 28822670.

纯度：≥98%

CAS：287403-39-8